Navamedic ASA (OSL:NAVA)
22.20
-0.30 (-1.33%)
Oct 24, 2025, 2:43 PM CET
Navamedic ASA Revenue
Navamedic ASA had revenue of 137.28M NOK in the quarter ending June 30, 2025, a decrease of -12.17%. This brings the company's revenue in the last twelve months to 523.56M, down -3.67% year-over-year. In the year 2024, Navamedic ASA had annual revenue of 531.44M with 3.80% growth.
Revenue (ttm)
523.56M
Revenue Growth
-3.67%
P/S Ratio
1.02
Revenue / Employee
12.47M
Employees
42
Market Cap
532.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 531.44M | 19.44M | 3.80% |
| Dec 31, 2023 | 512.00M | 129.86M | 33.98% |
| Dec 31, 2022 | 382.14M | 103.70M | 37.24% |
| Dec 31, 2021 | 278.44M | 68.56M | 32.67% |
| Dec 31, 2020 | 209.88M | 21.12M | 11.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 628.08M |
| Nordhealth AS | 578.17M |
| Photocure ASA | 522.86M |
| Omda AS | 458.96M |
| Vistin Pharma ASA | 452.25M |
| Gentian Diagnostics ASA | 163.38M |
| ContextVision AB | 122.97M |
| ArcticZymes Technologies ASA | 104.33M |